Stanford Cancer Institute

Cancer Clinical Trials Cooperative Group Activities

National Cancer Institute Cooperative Groups

National Cancer Institute (NCI) cooperative groups consist of networks of researchers who develop and conduct cancer treatment clinical trials throughout the nation. Emphasis is placed on the development and conduct of large, multicenter, randomized phase 3 studies.

The Stanford Cancer Institute (SCI) is active in the following NCI cooperative groups: 


For more information on SCI cooperative group activities, contact:

Yi Pang, MMed, MHA

Executive Administrative Director

National Cancer Institute Clinical Trials Network

The SCI is a recipient of a U10 Lead Academic Participating Site award as part of the National Cancer Institute's Clinical Trials Network (NCTN). Through this network we offer many NCTN trials as potential treatment options for our patients.

Our faculty are involved in:

  • Scientific contributions to the NCTN.
  • Participate as lead investigators on national multi-center cancer clinical trials.